Synapse

← Jerry R. McGhee

Papers by Jerry R. McGhee

Page 1 · newest first

  1. Inside the Mucosal Immune SystemPLoS Biology · 2012
  2. A Novel Adenovirus Expressing Flt3 Ligand Enhances Mucosal Immunity by Inducing Mature Nasopharyngeal-Associated Lymphoreticular Tissue Dendritic Cell MigrationThe Journal of Immunology · 2008
  3. Low-Dose Tolerance Is Mediated by the Microfold Cell Ligand, Reovirus Protein σ1The Journal of Immunology · 2008
  4. Nasal Cholera Toxin Elicits IL-5 and IL-5 Receptor α-Chain Expressing B-1a B Cells for Innate Mucosal IgA Antibody ResponsesThe Journal of Immunology · 2007
  5. Mucosal Vaccine Targeting Improves Onset of Mucosal and Systemic Immunity to Botulinum Neurotoxin AThe Journal of Immunology · 2006
  6. A Second Generation of Double Mutant Cholera Toxin Adjuvants: Enhanced Immunity without Intracellular TraffickingThe Journal of Immunology · 2006
  7. Bacillus anthracis Edema Toxin Acts as an Adjuvant for Mucosal Immune Responses to Nasally Administered Vaccine AntigensThe Journal of Immunology · 2006
  8. Enterotoxin-Based Mucosal Adjuvants Alter Antigen Trafficking and Induce Inflammatory Responses in the Nasal TractInfection and Immunity · 2005
  9. Peyer’s Patch Germinal Centers: The Elusive Switch Site for IgAThe Journal of Immunology · 2005
  10. The World of Th1/Th2 Subsets: First ProofThe Journal of Immunology · 2005
  11. A Novel Neurotoxoid Vaccine Prevents Mucosal BotulismThe Journal of Immunology · 2005
  12. Non-GMI Ganglioside-Targeting Bacterial Toxins and Derivatives with Mucosal Adjuvant ActivityInternational Journal of Oral-Medical Sciences · 2005
  13. Dendritic Cells Targeting Flt3 Ligand As Molecular Mucosal AdjuvantInternational Journal of Oral-Medical Sciences · 2005
  14. A Novel Adjuvant for Mucosal Immunity to HIV-1 gp120 in Nonhuman PrimatesThe Journal of Immunology · 2004
  15. Granulocyte chemotactic protein-2 mediates adaptive immunity in part through IL-8Rβ interactionsJournal of Leukocyte Biology · 2004
  16. Role of Gut-Associated Lymphoreticular Tissues in Antigen-Specific Intestinal IgA ImmunityThe Journal of Immunology · 2004
  17. Nasal Flt3 Ligand cDNA Elicits CD11c+CD8+ Dendritic Cells for Enhanced Mucosal ImmunityThe Journal of Immunology · 2004
  18. Pneumococcal carriage results in ganglioside-mediated olfactory tissue infectionProceedings of the National Academy of Sciences · 2003
  19. Cholera toxin activates dendritic cells through dependence on GM1‐ganglioside which is mediated by NF‐κB translocationEuropean Journal of Immunology · 2003
  20. IFN-γ-Inducible Chemokines Enhance Adaptive Immunity and ColitisJournal of Interferon & Cytokine Research · 2003
  21. Therapeutic Manipulation of the Immune System: Enhancement of Innate and Adaptive Mucosal ImmunityCurrent Pharmaceutical Design · 2003
  22. Effective Mucosal Immunity to Anthrax: Neutralizing Antibodies and Th Cell Responses Following Nasal Immunization with Protective AntigenThe Journal of Immunology · 2003
  23. Protective Mucosal Immunity in Aging Is Associated with Functional CD4+ T Cells in Nasopharyngeal-Associated Lymphoreticular TissueThe Journal of Immunology · 2003
  24. MIP-1α and MIP-1β differentially mediate mucosal and systemic adaptive immunityBlood · 2003
  25. Chimeras of Labile Toxin One and Cholera Toxin Retain Mucosal Adjuvanticity and Direct Th Cell Subsets Via Their B SubunitThe Journal of Immunology · 2003
  26. A Nontoxic Chimeric Enterotoxin Adjuvant Induces Protective Immunity in Both Mucosal and Systemic Compartments with Reduced IgE AntibodiesThe Journal of Infectious Diseases · 2002
  27. Resistance of T-Cell Receptor δ-Chain-Deficient Mice to ExperimentalCandidaalbicansVaginitisInfection and Immunity · 2001
  28. The Pulmonary Environment Promotes Th2 Cell Responses After Nasal-Pulmonary Immunization with Antigen Alone, but Th1 Responses Are Induced During Instances of Intense Immune StimulationThe Journal of Immunology · 2001
  29. Elimination of Colonic Patches with Lymphotoxin β Receptor-Ig Prevents Th2 Cell-Type ColitisThe Journal of Immunology · 2001
  30. Production of a recombinant hybrid molecule of cholera toxin‐B‐subunit and proteolipid‐protein‐peptide for the treatment of experimental encephalomyelitisBiotechnology and Bioengineering · 2001
  31. A Clinical Inflammatory Syndrome Attributable to Aerosolized Lipid–DNA Administration in Cystic FibrosisHuman Gene Therapy · 2001
  32. Immunoglobulin A (IgA) Responses and IgE-Associated Inflammation along the Respiratory Tract after Mucosal but Not Systemic ImmunizationInfection and Immunity · 2001
  33. Peyer's patches are required for oral tolerance to proteinsProceedings of the National Academy of Sciences · 2001
  34. Genetically Manipulated Bacterial Toxin as a New Generation Mucosal AdjuvantScandinavian Journal of Immunology · 2001
  35. Oral Tolerance Revisited: Prior Oral Tolerization Abrogates Cholera Toxin-Induced Mucosal IgA ResponsesThe Journal of Immunology · 2001
  36. Oral QS-21 Requires Early IL-4 Help for Induction of Mucosal and Systemic ImmunityThe Journal of Immunology · 2001
  37. Heterosubtypic Immunity to Influenza A Virus Infection Requires B Cells but Not CD8+Cytotoxic T LymphocytesThe Journal of Infectious Diseases · 2001
  38. Measurement of TGF ‐β in Biological FluidsCurrent Protocols in Immunology · 2001
  39. A revisit of mucosal IgA immunity and oral toleranceActa Odontologica Scandinavica · 2001
  40. RANTES Potentiates Antigen-Specific Mucosal Immune ResponsesThe Journal of Immunology · 2001
  41. Evidence For Early Aging in the Mucosal Immune SystemThe Journal of Immunology · 2000
  42. Cutting Edge: The Mucosal Adjuvant Cholera Toxin Redirects Vaccine Proteins into Olfactory TissuesThe Journal of Immunology · 2000
  43. Human C-Reactive Protein Is Protective against FatalSalmonella entericaSerovar Typhimurium Infection in Transgenic MiceInfection and Immunity · 2000
  44. Enterotoxin-Specific Immunoglobulin E Responses in Humans after Infection or Vaccination with Diarrhea-Causing EnteropathogensInfection and Immunity · 2000
  45. Enterotoxin Adjuvants Have Direct Effects on T Cells and Antigen‐Presenting Cells That Result in Either Interleukin‐4–Dependent or –Independent Immune ResponsesThe Journal of Infectious Diseases · 2000
  46. Complement-Dependent Acute-Phase Expression of C-Reactive Protein and Serum Amyloid P-ComponentThe Journal of Immunology · 2000
  47. Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccineAIDS · 2000
  48. Gamma Interferon Is Not Required for Mucosal Cytotoxic T-Lymphocyte Responses or Heterosubtypic Immunity to Influenza A Virus Infection in MiceJournal of Virology · 2000
  49. Protective Immunity to Rotavirus Shedding in the Absence of Interleukin-6: Th1 Cells and Immunoglobulin A Develop NormallyJournal of Virology · 2000
  50. Alternate Mucosal Immune System: Organized Peyer’s Patches Are Not Required for IgA Responses in the Gastrointestinal TractThe Journal of Immunology · 2000